Loading clinical trials...
Loading clinical trials...
Effectiveness of Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment (A Randomized Controlled Clinical Trial)
The aim of this study is to assess the efficacy of Dexmedetomidine drug either used sublingually or intranasally in managing healthy children during dental treatment
Each child should fulfill the requirements of having a dental condition which needs treatment in two dental sessions, where each session should not exceed thirty minutes. At the first visit ,either sublingual or intranasal Dexmedetomidine will be used, while at the second visit the alternate route will be implemented in a cross-over design. At least one week interval between the two visits will be secured.
Age
5 - 7 years
Sex
ALL
Healthy Volunteers
No
Faculty of Dentistry, Alexandria University
Alexandria, Egypt
Start Date
August 27, 2019
Primary Completion Date
August 1, 2020
Completion Date
August 10, 2020
Last Updated
October 29, 2020
42
ACTUAL participants
Intranasal Dexmedetomidine
DRUG
Sublingual Dexmedetomidine
DRUG
Lead Sponsor
Nourhan M.Aly
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01731106